FRIENDLY CORPORATION Logo

FRIENDLY CORPORATION

Offers digital solutions for business growth: web production, marketing, e-commerce, & incubation.

8209 | T

Overview

Corporate Details

ISIN(s):
JP3829200009
LEI:
Country:
Japan
Address:
大東市寺川3丁目12番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Friendly Corporation is a creative company that provides comprehensive digital solutions to address corporate and social challenges. The firm specializes in a range of services designed to support business growth, including website production focused on brand storytelling and marketing outcomes. Its core offerings also encompass social media (SNS) and marketing consulting, advertising agency services, full-service e-commerce business support, and end-to-end new business incubation. The company partners with clients throughout the entire business lifecycle, from initial idea generation and strategic planning to product development, market entry, and acceleration.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 08:00
Report Publication Announcement
確認書
Japanese 8.7 KB
2025-11-10 08:00
Interim Report
半期報告書-第72期(2025/04/01-2026/03/31)
Japanese 214.9 KB
2025-06-30 03:26
Post-Annual General Meeting Information
臨時報告書
Japanese 23.4 KB
2025-06-27 05:01
Governance Information
内部統制報告書-第71期(2024/04/01-2025/03/31)
Japanese 23.1 KB
2025-06-27 05:00
Registration Form
有価証券報告書-第71期(2024/04/01-2025/03/31)
Japanese 760.7 KB
2025-06-27 05:00
Registration Form
確認書
Japanese 8.6 KB
2025-05-09 09:00
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2025-04-14 04:08
Board/Management Information
臨時報告書
Japanese 20.6 KB
2025-02-10 08:00
Regulatory News Service
臨時報告書
Japanese 18.3 KB
2024-11-08 08:01
Regulatory News Service
臨時報告書
Japanese 18.2 KB
2024-11-08 08:00
Interim Report
確認書
Japanese 8.7 KB
2024-11-08 08:00
Interim Report
半期報告書-第51期(2024/04/01-2025/03/31)
Japanese 216.0 KB
2024-06-28 03:00
Regulatory News Service
訂正臨時報告書
Japanese 22.6 KB
2024-06-24 04:58
Post-Annual General Meeting Information
臨時報告書
Japanese 23.1 KB
2024-06-24 03:01
Regulatory News Service
臨時報告書
Japanese 18.1 KB

Automate Your Workflow. Get a real-time feed of all FRIENDLY CORPORATION filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for FRIENDLY CORPORATION

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for FRIENDLY CORPORATION via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Poxel Logo
Develops drugs for metabolic diseases, including NASH, rare diseases, and an approved diabetes drug.
France
POXEL
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan
2449
Predictive Oncology Inc. Logo
AI platform uses a vast tumor biobank to predict drug response and accelerate oncology discovery.
United States of America
POAI
Prime Medicine, Inc. Logo
Developing 'search and replace' gene editing therapies to treat genetic disorders.
United States of America
PRME
ProPhase Labs, Inc. Logo
Genomics, diagnostics, contract manufacturing, and OTC health & wellness solutions provider.
United States of America
PRPH
PROTHENA CORP PUBLIC LTD CO Logo
Advancing antibody-based therapies for neurodegenerative and rare amyloid diseases.
United States of America
PRTA
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America
950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America
PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel
PPBT
Qualigen Therapeutics, Inc. Logo
A clinical-stage company developing innovative treatments for rare cancers in adults and children.
United States of America
QLGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.